{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T14:45:25Z","timestamp":1792421125770,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T00:00:00Z","timestamp":1552435200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s10096-019-03528-9","type":"journal-article","created":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T23:00:06Z","timestamp":1552518006000},"page":"937-944","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Inappropriate empirical antibiotic therapy does not adversely affect the clinical outcomes of patients with acute pyelonephritis caused by extended-spectrum \u03b2-lactamase-producing Enterobacteriales"],"prefix":"10.1007","volume":"38","author":[{"given":"Si-Ho","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhyun","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyungmin","family":"Huh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Young","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheol-In","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doo Ryeon","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyong Ran","family":"Peck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,13]]},"reference":[{"issue":"3","key":"3528_CR1","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S1473-3099(08)70041-0","volume":"8","author":"JD Pitout","year":"2008","unstructured":"Pitout JD, Laupland KB (2008) Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 8(3):159\u2013166","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"3528_CR2","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.ijantimicag.2010.05.009","volume":"36","author":"CI Kang","year":"2010","unstructured":"Kang CI, Song JH, Chung DR, Peck KR, Ko KS, Yeom JS, Ki HK, Son JS, Lee SS, Kim YS, Jung SI, Kim SW, Chang HH, Ryu SY, Kwon KT, Lee H, Moon C, Shin SY, Korean Network for Study of Infectious D (2010) Risk factors and treatment outcomes of community-onset bacteraemia caused by extended-spectrum beta-lactamase-producing Escherichia coli. Int J Antimicrob Agents 36(3):284\u2013287","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"3528_CR3","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/jhm.2157","volume":"9","author":"SH MacVane","year":"2014","unstructured":"MacVane SH, Tuttle LO, Nicolau DP (2014) Impact of extended-spectrum beta-lactamase-producing organisms on clinical and economic outcomes in patients with urinary tract infection. J Hosp Med 9(4):232\u2013238","journal-title":"J Hosp Med"},{"issue":"16","key":"3528_CR4","doi-asserted-by":"publisher","first-page":"e6648","DOI":"10.1097\/MD.0000000000006648","volume":"96","author":"CH Lee","year":"2017","unstructured":"Lee CH, Chu FY, Hsieh CC, Hong MY, Chi CH, Ko WC, Lee CC (2017) A simple scoring algorithm predicting extended-spectrum beta-lactamase producers in adults with community-onset monomicrobial Enterobacteriaceae bacteremia: matters of frequent emergency department users. Medicine (Baltimore) 96(16):e6648","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"3528_CR5","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/CCM.0000000000002255","volume":"45","author":"A Rhodes","year":"2017","unstructured":"Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME, Rochwerg B, Rubenfeld GD, Angus DC, Annane D, Beale RJ, Bellinghan GJ, Bernard GR, Chiche JD, Coopersmith C, De Backer DP, French CJ, Fujishima S, Gerlach H, Hidalgo JL, Hollenberg SM, Jones AE, Karnad DR, Kleinpell RM, Koh Y, Lisboa TC, Machado FR, Marini JJ, Marshall JC, Mazuski JE, McIntyre LA, McLean AS, Mehta S, Moreno RP, Myburgh J, Navalesi P, Nishida O, Osborn TM, Perner A, Plunkett CM, Ranieri M, Schorr CA, Seckel MA, Seymour CW, Shieh L, Shukri KA, Simpson SQ, Singer M, Thompson BT, Townsend SR, Van der Poll T, Vincent JL, Wiersinga WJ, Zimmerman JL, Dellinger RP (2017) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Crit Care Med 45(3):486\u2013552","journal-title":"Crit Care Med"},{"issue":"10","key":"3528_CR6","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1086\/502310","volume":"25","author":"CI Kang","year":"2004","unstructured":"Kang CI, Kim SH, Kim DM, Park WB, Lee KD, Kim HB, Oh MD, Kim EC, Choe KW (2004) Risk factors for and clinical outcomes of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae. Infect Control Hosp Epidemiol 25(10):860\u2013867","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"6","key":"3528_CR7","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1128\/AAC.01509-06","volume":"51","author":"M Tumbarello","year":"2007","unstructured":"Tumbarello M, Sanguinetti M, Montuori E, Trecarichi EM, Posteraro B, Fiori B, Citton R, D'Inzeo T, Fadda G, Cauda R, Spanu T (2007) Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. Antimicrob Agents Chemother 51(6):1987\u20131994","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"3528_CR8","doi-asserted-by":"publisher","first-page":"3244","DOI":"10.1128\/AAC.00063-08","volume":"52","author":"M Tumbarello","year":"2008","unstructured":"Tumbarello M, Sali M, Trecarichi EM, Leone F, Rossi M, Fiori B, De Pascale G, D'Inzeo T, Sanguinetti M, Fadda G, Cauda R, Spanu T (2008) Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy. Antimicrob Agents Chemother 52(9):3244\u20133252","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"3528_CR9","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s15010-011-0201-x","volume":"39","author":"FG Rosa De","year":"2011","unstructured":"De Rosa FG, Pagani N, Fossati L, Raviolo S, Cometto C, Cavallerio P, Parlato C, Guglielmi E, Serra R, Di Perri G (2011) The effect of inappropriate therapy on bacteremia by ESBL-producing bacteria. Infection 39(6):555\u2013561","journal-title":"Infection"},{"issue":"3","key":"3528_CR10","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3109\/00365548.2012.730151","volume":"45","author":"CI Kang","year":"2013","unstructured":"Kang CI, Sung YK, Lee KH, Lee KT, Lee JK (2013) Clinical impact of inappropriate initial antimicrobial therapy on outcome in bacteremic biliary tract infections. Scand J Infect Dis 45(3):227\u2013234","journal-title":"Scand J Infect Dis"},{"issue":"7","key":"3528_CR11","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1128\/AAC.01523-12","volume":"57","author":"FN Frakking","year":"2013","unstructured":"Frakking FN, Rottier WC, Dorigo-Zetsma JW, van Hattem JM, van Hees BC, Kluytmans JA, Lutgens SP, Prins JM, Thijsen SF, Verbon A, Vlaminckx BJ, Cohen Stuart JW, Leverstein-van Hall MA, Bonten MJ (2013) Appropriateness of empirical treatment and outcome in bacteremia caused by extended-spectrum-beta-lactamase-producing bacteria. Antimicrob Agents Chemother 57(7):3092\u20133099","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"3528_CR12","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1007\/s10096-017-3031-7","volume":"36","author":"EJ Joo","year":"2017","unstructured":"Joo EJ, Park DA, Lee NR, Moon SY, Choi JK, Ko JH, Peck KR (2017) Impact of appropriateness of empiric therapy on outcomes in community-onset bacteremia by extended-spectrum-beta-lactamase producing Escherichia coli and Klebisella pneumoniae definitively treated with carbapenems. Eur J Clin Microbiol Infect Dis 36(11):2093\u20132100","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"3528_CR13","doi-asserted-by":"publisher","first-page":"e0190910","DOI":"10.1371\/journal.pone.0190910","volume":"13","author":"F Madhi","year":"2018","unstructured":"Madhi F, Jung C, Timsit S, Levy C, Biscardi S, Lorrot M, Grimprel E, Hees L, Craiu I, Galerne A, Dubos F, Cixous E, Hentgen V, Bechet S, Urinary-tract Infection Due to Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae in Children G, Bonacorsi S, Cohen R (2018) Febrile urinary-tract infection due to extended-spectrum beta-lactamase-producing Enterobacteriaceae in children: a French prospective multicenter study. PLoS One 13(1):e0190910","journal-title":"PLoS One"},{"issue":"3","key":"3528_CR14","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s15010-013-0441-z","volume":"41","author":"B Kim","year":"2013","unstructured":"Kim B, Kim J, Seo MR, Wie SH, Cho YK, Lim SK, Lee JS, Kwon KT, Lee H, Cheong HJ, Park DW, Ryu SY, Chung MH, Ki M, Pai H (2013) Clinical characteristics of community-acquired acute pyelonephritis caused by ESBL-producing pathogens in South Korea. Infection 41(3):603\u2013612","journal-title":"Infection"},{"issue":"1","key":"3528_CR15","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ijantimicag.2017.09.013","volume":"51","author":"SA Kim","year":"2018","unstructured":"Kim SA, Altshuler J, Paris D, Fedorenko M (2018) Cefepime versus carbapenems for the treatment of urinary tract infections caused by extended-spectrum beta-lactamase-producing enterobacteriaceae. Int J Antimicrob Agents 51(1):155\u2013158","journal-title":"Int J Antimicrob Agents"},{"key":"3528_CR16","doi-asserted-by":"crossref","unstructured":"Kim S-H, Huh K, Cho SY, Kang C-I, Chung DR, Peck KR (2018) Factors associated with the recurrence of acute pyelonephritis caused by extended-Spectrum \u03b2-lactamase-producing Escherichia coli: the importance of infectious disease consultation. Diagn Microbiol Infect Dis","DOI":"10.1016\/j.diagmicrobio.2018.11.019"},{"issue":"7725","key":"3528_CR17","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/S0140-6736(71)80066-1","volume":"2","author":"KF Fairley","year":"1971","unstructured":"Fairley KF, Carson NE, Gutch RC, Leighton P, Grounds AD, Laird EC, McCallum PH, Sleeman RL, O\u2019Keefe CM (1971) Site of infection in acute urinary-tract infection in general practice. Lancet 2(7725):615\u2013618","journal-title":"Lancet"},{"key":"3528_CR18","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1741-7015-12-40","volume":"12","author":"T Cardoso","year":"2014","unstructured":"Cardoso T, Almeida M, Friedman ND, Aragao I, Costa-Pereira A, Sarmento AE, Azevedo L (2014) Classification of healthcare-associated infection: a systematic review 10 years after the first proposal. BMC Med 12:40","journal-title":"BMC Med"},{"issue":"5","key":"3528_CR19","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373\u2013383","journal-title":"J Chronic Dis"},{"key":"3528_CR20","unstructured":"U.S. Department of Health and Human Services Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0. \n                    https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/CTCAE_v5_Quick_Reference_8.5x11.pdf\n                    \n                  . Accessed 1 Nov 2018"},{"issue":"8","key":"3528_CR21","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.jiac.2017.05.005","volume":"23","author":"C Malaisri","year":"2017","unstructured":"Malaisri C, Phuphuakrat A, Wibulpolprasert A, Santanirand P, Kiertiburanakul S (2017) A randomized controlled trial of sitafloxacin vs. ertapenem as a switch therapy after treatment for acute pyelonephritis caused by extended-spectrum beta-lactamase-producing Escherichia coli: a pilot study. J Infect Chemother 23(8):556\u2013562","journal-title":"J Infect Chemother"},{"key":"3528_CR22","first-page":"89","volume-title":"Sample size calculations in clinical research","author":"S Chow","year":"2008","unstructured":"Chow S, Shao J, Wang H (2008) Sample size calculations in clinical research, 2nd edn, p 89","edition":"2"},{"issue":"5","key":"3528_CR23","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1093\/jac\/dkm318","volume":"60","author":"MJ Schwaber","year":"2007","unstructured":"Schwaber MJ, Carmeli Y (2007) Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. J Antimicrob Chemother 60(5):913\u2013920","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"3528_CR24","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1093\/cid\/ciw425","volume":"63","author":"KE Goodman","year":"2016","unstructured":"Goodman KE, Lessler J, Cosgrove SE, Harris AD, Lautenbach E, Han JH, Milstone AM, Massey CJ, Tamma PD, Antibacterial Resistance Leadership G (2016) A clinical decision tree to predict whether a bacteremic patient is infected with an extended-spectrum beta-lactamase-producing organism. Clin Infect Dis 63(7):896\u2013903","journal-title":"Clin Infect Dis"},{"issue":"2","key":"3528_CR25","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ajem.2012.07.024","volume":"31","author":"CC Lee","year":"2013","unstructured":"Lee CC, Chang CM, Hong MY, Hsu HC, Ko WC (2013) Different impact of the appropriateness of empirical antibiotics for bacteremia among younger adults and the elderly in the ED. Am J Emerg Med 31(2):282\u2013290","journal-title":"Am J Emerg Med"},{"issue":"6","key":"3528_CR26","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1128\/AAC.06212-11","volume":"56","author":"JH Jeon","year":"2012","unstructured":"Jeon JH, Kim K, Han WD, Song SH, Park KU, Rhee JE, Song KH, Park WB, Kim ES, Park SW, Kim NJ, Oh MD, Kim HB (2012) Empirical use of ciprofloxacin for acute uncomplicated pyelonephritis caused by Escherichia coli in communities where the prevalence of fluoroquinolone resistance is high. Antimicrob Agents Chemother 56(6):3043\u20133046","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"3528_CR27","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3904\/kjim.2016.31.1.145","volume":"31","author":"UI Chang","year":"2016","unstructured":"Chang UI, Kim HW, Wie SH (2016) Use of cefuroxime for women with community-onset acute pyelonephritis caused by cefuroxime-susceptible or -resistant Escherichia coli. Korean J Intern Med 31(1):145\u2013155","journal-title":"Korean J Intern Med"},{"issue":"3","key":"3528_CR28","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.diagmicrobio.2017.07.011","volume":"89","author":"I Greenhouse","year":"2017","unstructured":"Greenhouse I, Babushkin F, Finn T, Shimoni Z, Aliman M, Ben-Ami R, Cohen R (2017) Long-term outcomes of inappropriate antibiotic therapy for upper urinary tract infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae: a retrospective cohort study. Diagn Microbiol Infect Dis 89(3):222\u2013229","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"5","key":"3528_CR29","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1093\/cid\/ciq257","volume":"52","author":"K Gupta","year":"2011","unstructured":"Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, Moran GJ, Nicolle LE, Raz R, Schaeffer AJ, Soper DE, Infectious Diseases Society of A, European Society for M, Infectious D (2011) International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 52(5):e103\u2013e120","journal-title":"Clin Infect Dis"},{"issue":"4","key":"3528_CR30","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1128\/CMR.18.4.657-686.2005","volume":"18","author":"DL Paterson","year":"2005","unstructured":"Paterson DL, Bonomo RA (2005) Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 18(4):657\u2013686","journal-title":"Clin Microbiol Rev"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-019-03528-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-019-03528-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-019-03528-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T14:17:56Z","timestamp":1567088276000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-019-03528-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,13]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["3528"],"URL":"https:\/\/doi.org\/10.1007\/s10096-019-03528-9","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,13]]},"assertion":[{"value":"8 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The study was approved by the local ethical research committee (IRB number: 2018\u201305-089).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}]}}